Restoration of Glucokinase Expression in the Liver Normalizes Postprandial Glucose Disposal in Mice With Hepatic Deficiency of PDK1

Phosphoinositide-dependent kinase-1 (PDK1) is implicated in the metabolic effects of insulin as a key mediator of phosphoinositide 3-kinase–dependent signaling. Here we show that mice with liver-specific PDK1 deficiency manifest various defects in the metabolic actions of insulin in the liver as well as a type 2 diabetes–like phenotype characterized by marked hyperinsulinemia and postprandial hyperglycemia. The hepatic abundance of glucokinase, an important determinant of glucose flux and glucose-evoked signaling in hepatocytes, was substantially reduced in these mice. Restoration of hepatic glucokinase expression, with the use of an adenoviral vector, induced insulin-like effects in the liver and almost completely normalized the fasting hyperinsulinemia and postprandial hyperglycemia in these animals. These results indicate that, if the hepatic abundance of glucokinase is maintained, ingested glucose is normally disposed of even in the absence of acute activation of proximal insulin signaling, such as the activation of Akt, in the liver.

[1]  C. Newgard,et al.  The Repression of Hormone-activated PEPCK Gene Expression by Glucose Is Insulin-independent but Requires Glucose Metabolism* , 1998, The Journal of Biological Chemistry.

[2]  Y. Matsuki,et al.  Role of Krüppel-like factor 15 in PEPCK gene expression in the liver. , 2005, Biochemical and biophysical research communications.

[3]  M. Kasuga,et al.  Role of the insulin receptor substrate 1 and phosphatidylinositol 3-kinase signaling pathway in insulin-induced expression of sterol regulatory element binding protein 1c and glucokinase genes in rat hepatocytes. , 2002, Diabetes.

[4]  Dario R. Alessi,et al.  The insulin signalling pathway , 2002, Current Biology.

[5]  R. O’Brien,et al.  Regulation of gene expression by insulin. , 1991, Physiological reviews.

[6]  M. Kasuga,et al.  Requirement for Activation of the Serine-Threonine Kinase Akt (Protein Kinase B) in Insulin Stimulation of Protein Synthesis but Not of Glucose Transport , 1998, Molecular and Cellular Biology.

[7]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[8]  Hui Chen,et al.  Substitution of the Autophosphorylation Site Thr516with a Negatively Charged Residue Confers Constitutive Activity to Mouse 3-Phosphoinositide-dependent Protein Kinase-1 in Cells* , 2002, The Journal of Biological Chemistry.

[9]  C. Kahn,et al.  Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. , 2006, Cell metabolism.

[10]  T. Noda,et al.  PKClambda in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity. , 2003, The Journal of clinical investigation.

[11]  P. Cohen,et al.  The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells , 2000, Current Biology.

[12]  R. Roth,et al.  Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation by an Akt/Phosphatidylinositol 3-Kinase Pathway* , 1999, The Journal of Biological Chemistry.

[13]  F. Bosch,et al.  Correction of diabetic alterations by glucokinase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Kellendonk,et al.  Hepatocyte‐specific expression of Cre recombinase , 2000, Genesis.

[15]  C. Kahn,et al.  Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. , 2000, Molecular cell.

[16]  F. Tronche,et al.  Deficiency of PDK1 in liver results in glucose intolerance, impairment of insulin-regulated gene expression and liver failure. , 2005, The Biochemical journal.

[17]  M. Magnuson,et al.  Hepatic Glucokinase Is Required for the Synergistic Action of ChREBP and SREBP-1c on Glycolytic and Lipogenic Gene Expression* , 2004, Journal of Biological Chemistry.

[18]  E. Joslin,et al.  Joslin's Diabetes Mellitus , 1971 .

[19]  M. Magnuson,et al.  Dual Roles for Glucokinase in Glucose Homeostasis as Determined by Liver and Pancreatic β Cell-specific Gene Knock-outs Using Cre Recombinase* , 1999, The Journal of Biological Chemistry.

[20]  Y. Kido,et al.  Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo , 2004, Nature Medicine.

[21]  R. O’Brien,et al.  Regulation of gene expression by insulin. , 1996, The Biochemical journal.

[22]  Y. Kido,et al.  Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. , 2006, Nature genetics.

[23]  H. Sone,et al.  Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. , 2004, Diabetes.

[24]  C. Newgard,et al.  Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia. , 1999, Diabetes.

[25]  F. Bosch,et al.  Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Prescott,et al.  Essential role of PDK1 in regulating cell size and development in mice , 2002, The EMBO journal.

[28]  Y. Kido,et al.  Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass , 2006, Nature Genetics.

[29]  J. Radziuk,et al.  Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis , 2001, Diabetes/metabolism research and reviews.

[30]  J. Castaño Regulation of gene expression by insulin. , 1991, Advances in enzyme regulation.

[31]  M. Kasuga,et al.  Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. , 2002, The Journal of clinical investigation.

[32]  D. Accili,et al.  Differential regulation of gene expression by insulin and IGF‐1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR , 2000, The EMBO journal.

[33]  S. Akira,et al.  Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. , 2006, Cell metabolism.

[34]  W Ogawa,et al.  Insulin-Induced Phosphorylation and Activation of Cyclic Nucleotide Phosphodiesterase 3B by the Serine-Threonine Kinase Akt , 1999, Molecular and Cellular Biology.

[35]  R. Printz,et al.  Tweaking the glucose sensor: adjusting glucokinase activity with activator compounds. , 2005, Endocrinology.

[36]  D. Alessi,et al.  Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia , 2003, The EMBO journal.